[Clinical efficacy of restrictive fluid management in patients with severe traumatic brain injury].

OBJECTIVE

To investigate the effects of restrictive fluid management in patients with severe traumatic brain injury (sTBI).

METHODS

Between January, 2019 and June, 2020, we randomly assigned 51 postoperative patients (stay in the ICU of no less than 7 days) with sTBI into treatment group (=25) with restrictive fluid management and the control group (=26) with conventional fluid management. The data of optic nerve sheath diameter (ONSD), middle cerebral artery pulsatility index (MAC- PI), neuron-specific enolase (NSE) level, inferior vena cava (IVC) diameter, Glascow Coma Scale (GCS) score, mean arterial blood pressure, heart rate, and fluid balance of the patients were collected at ICU admission and at 1, 3 and 7 days after ICU admission, and the duration of mechanical ventilation, ICU stay, and 28-day mortality were recorded.

RESULTS

The cumulative fluid balance of the two groups were positive on day 1 and negative on days 3 and 7 after ICU admission; at the same time points, the patients in the treatment group had significantly greater negative fluid balance than those in the control group ( < 0.05). In both of the groups, the ONSD and MCA-PI values were significantly higher on day 1 than the baseline ( < 0.05), reached the peak levels on day 3, and decreased on day 7; at the same time point, these values were significantly lower in the treatment group than in the control group ( < 0.05). No significant difference was found in NSE level on day 1 between the two groups (>0.05); on day 3, NSE level reached the peak level and was significantly higher in the control group ( < 0.05); on day 7, NSE level was lowered the level of day 1 in the treatment group but remained higher than day 1 level in the control group. The 28-day mortality rate did not differ significantly between the two groups (16.00% 23.08%, >0.05); the duration of mechanical ventilation, length of ICU stay, and the number of tracheotomy were all significantly shorter or lower in the treatment group than in the control group ( < 0.05).

CONCLUSIONS

Restrictive fluid management can reduce cerebral edema and improve the prognosis but does not affect the 28-day mortality of patients with sTBI.